When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. J&J boosts heart device business in $13.1 billion Shockwave deal

   www.aol.com/news/johnson-johnson-buy-shockwave...

   The offer also represents a 17% premium to the stock's closing price in late March, when the Wall Street Journal reported J&J's interest in Shockwave, whose shares were currently trading at $326.82.

3. J&J to pump another $13B into its MedTech business with ...

   www.aol.com/news/j-j-pump-another-13b-125626976.html

   J&J's Shockwave deal still needs approvals from regulators and shareholders. The companies expect to close the acquisition by the middle of this year. Shares of New Brunswick, New Jersey-based J&J ...

4. J&J in talks to buy Shockwave Medical, WSJ reports - AOL

   www.aol.com/news/j-j-talks-buy-shockwave...

   When contacted for comment on the WSJ report, J&J and Shockwave Medical said they do not comment on rumors or speculation. News of the talks lifted shares of Shockwave Medical up 11.5% in ...

5. Johnson & Johnson - Wikipedia

   en.wikipedia.org/wiki/Johnson_&_Johnson

   J&J spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a J&J executive in charge of consumer products. [197] In response to declining demand, J&J announced it would discontinue the sale of talc-based baby powder in the United States and Canada in 2020, but would continue to sell ...

6. Ethicon - Wikipedia

   en.wikipedia.org/wiki/Ethicon

   In 2009, Ethicon acquired breast implant maker Mentor, [8] [9] and in 2010 it acquired ear, nose and throat technology company Acclarent. [10] In 2016, Ethicon acquired NeuWave Medical. [11] In 2013, J&J merged Ethicon Endo-Surgery back into Ethicon. [6] As of September 10, 2024, Ethicon began operating under the name Johnson & Johnson MedTech ...

7. Technicare - Wikipedia

   en.wikipedia.org/wiki/Technicare

   The DR 960 was introduced in 1982 as a digital subtraction angiography device. Rather than injecting contrast material into an artery, contrast was injected into the corresponding vein. A digital image was acquired without contrast and one with, and the images subtracted from each other leaving the arterial branch highlighted with contrast.

8. Janssen Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Janssen_Pharmaceuticals

   In 1961, Janssen Pharmaceuticals was purchased by New Jersey–based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical ...

9. J&J to buy cancer therapy developer Ambrx for $2 billion - AOL

   www.aol.com/news/j-j-buy-cancer-therapy...

   J&J's acquisition is the latest deal announced in the space. J&J will pay $28 per share of Ambrx, which represents a premium of about 105% to the stock's last close. Ambrx is developing therapies ...